The company has promoted Marc Evanchik to the position of Chief Scientific Officer to oversee clinical development, research, and scientific strategy. Concurrently, Brittany de Temple has joined as the Senior Vice President of Development Operations to enhance preparedness for expanded clinical operations. These key appointments come amidst the company's progress towards the upcoming launch of global initiatives.